Literature DB >> 3160842

Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid. II. Longitudinal changes during periodontal therapy.

C E Niekrash, M R Patters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3160842     DOI： 10.1111/j.1600-0765.1985.tb00434.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN： 0022-3484            Impact factor:   4.419


× No keyword cloud information.
  16 in total

1.  Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.

Authors:  C W Cutler; J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 2.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

3.  Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis.

Authors:  Nagihan Bostanci; Kai Bao; Xiaofei Li; Tomoki Maekawa; Jonas Grossmann; Christian Panse; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Cristina A G Garcia; Edimara S Reis; John D Lambris; George Hajishengallis
Journal:  J Proteome Res       Date:  2018-08-29       Impact factor: 4.466

Review 4.  Complement and periodontitis.

Authors:  George Hajishengallis
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

5.  Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3.

Authors:  Tomoki Maekawa; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Evlambia Hajishengallis; Tetsuhiro Kajikawa; Sophia Koutsogiannaki; Cristina A G Garcia; Daniel Ricklin; John D Lambris; George Hajishengallis
Journal:  J Clin Periodontol       Date:  2016-03-03       Impact factor: 8.728

Review 6.  C3-targeted therapy in periodontal disease: moving closer to the clinic.

Authors:  George Hajishengallis; Hatice Hasturk; John D Lambris
Journal:  Trends Immunol       Date:  2021-09-02       Impact factor: 19.709

Review 7.  Role of complement in host-microbe homeostasis of the periodontium.

Authors:  George Hajishengallis; Toshiharu Abe; Tomoki Maekawa; Evlambia Hajishengallis; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-16       Impact factor: 11.130

Review 8.  Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.

Authors:  D C Mastellos; D Ricklin; E Hajishengallis; G Hajishengallis; J D Lambris
Journal:  Mol Oral Microbiol       Date:  2015-10-07       Impact factor: 3.563

Review 9.  Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.

Authors:  George Hajishengallis; Tomoki Maekawa; Toshiharu Abe; Evlambia Hajishengallis; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 10.  Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application.

Authors:  George Hajishengallis; Evlambia Hajishengallis; Tetsuhiro Kajikawa; Baomei Wang; Despina Yancopoulou; Daniel Ricklin; John D Lambris
Journal:  Semin Immunol       Date:  2016-03-24       Impact factor: 11.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.